The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Plasticity and cross-talk of Interleukin 6-type cytokines
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 3×
“[6].”
BackgroundSelf-citationThe pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Self-citationOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Self-citationThe inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
The Liver: Biology and Pathobiology.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-690_3 · Cited by 1,590
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00324-2 · Cited by 1,462
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213
Fried, S. K. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.847 · Cited by 1,145
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes
Castell, J. V., Gómez-Lechón, M. J., David, M., Andus, T., Geiger, T., Trullenque, R., Fabra, R., & Heinrich, P. C. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80476-4 · Cited by 893
SOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
Soluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Self-citationTherapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Self-citationFunctional interactions between Stat5 and the glucocorticoid receptor
Stöcklin, E., Wissler, M., Gouilleux, F., & Groner, B. (1996) · Nature · doi:10.1038/383726a0 · Cited by 675
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Self-citationHaemopoietic receptors and helical cytokines
Bazan, J. F. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90139-z · Cited by 638
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604
Bazan, J. F. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91528-3 · Cited by 546
ADAM17: a molecular switch to control inflammation and tissue regeneration
Scheller, J., Chalaris, A., Garbers, C., & Rose-John, S. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.005 · Cited by 526
Self-citationChronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477
SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling
Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15985 · Cited by 468
The composition and signaling of the IL-35 receptor are unconventional
Collison, L. W., Delgoffe, G. M., Guy, C. S., Vignali, K. M., Chaturvedi, V., Fairweather, D., Satoskar, A. R., Garcia, K. C., Hunter, C. A., Drake, C. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2227 · Cited by 450
Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist
Gillessen, S., Carvajal, D., Ling, P., Podlaski, F. J., Stremlo, D. L., Familletti, P. C., Gubler, U., Presky, D. H., Stern, A. S., & Gately, M. K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250133 · Cited by 436
Structural Biology of Shared Cytokine Receptors
Wang, X., Lupardus, P., LaPorte, S. L., & Garcia, K. C. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090616 · Cited by 408
Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.
Ling, P., Gately, M. K., Gubler, U., Stern, A. S., Lin, P., Hollfelder, K., Su, C., Pan, Y. C. E., & Hakimi, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.116 · Cited by 399
Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P. C., & Schaper, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12848 · Cited by 388
Self-citationDual Oncostatin M (OSM) Receptors
Mosley, B., De Imus, C., Friend, D., Boiani, N., Thoma, B., Park, L. S., & Cosman, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32635 · Cited by 386
Bethin, K. E., Vogt, S. K., & Muglia, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9317 · Cited by 381
Bode, J. G., Albrecht, U., Häussinger, D., Heinrich, P. C., & Schaper, F. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.09.008 · Cited by 379
Self-citationThe IL-6/sIL-6R complex as a novel target for therapeutic approaches
Rose-John, S., Waetzig, G. H., Scheller, J., Grötzinger, J., & Seegert, D. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.613 · Cited by 360
Self-citationThe role of the glucocorticoid receptor in inflammation and immunity
Baschant, U., & Tuckermann, J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.058 · Cited by 352
Baumann, H., Richards, C., & Gauldie, J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4122 · Cited by 351
Released Form of CNTF Receptor α Component as a Soluble Mediator of CNTF Responses
Davis, S., Aldrich, T. H., Ip, N. Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P. S., Curtis, R., Panayotatos, N., Gascan, H., et al. (1993) · Science · doi:10.1126/science.7681218 · Cited by 350
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
Matthews, V. B., Allen, T. L., Risis, S., Chan, M. H. S., Henstridge, D. C., Watson, N., Zaffino, L. A., Babb, J. R., Boon, J., Meikle, P. J., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1865-y · Cited by 334
Devergne, O., Birkenbach, M., & Kieff, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12041 · Cited by 326
The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., & Scheller, J. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.10.007 · Cited by 289
Self-citationMatsubara, T., Mita, A., Minami, K., Hosooka, T., Kitazawa, S., Takahashi, K., Tamori, Y., Yokoi, N., Watanabe, M., Matsuo, E.-I., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.002 · Cited by 286
Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor
Mooney, R. A., Senn, J., Cameron, S., Inamdar, N., Boivin, L. M., Shang, Y., & Furlanetto, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010579200 · Cited by 282
Babon, J. J., Kershaw, N. J., Murphy, J. M., Varghese, L. N., Laktyushin, A., Young, S. N., Lucet, I. S., Norton, R. S., & Nicola, N. A. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.015 · Cited by 279
The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimer
Mattner, F., Fischer, S., Guckes, S., Jin, S., Kaulen, H., Schmitt, E., Rüde, E., & Germann, T. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230923 · Cited by 279
Interleukin-6 depletion selectively improves hepatic insulin action in obesity.
Klover, P. J., Clementi, A. H., & Mooney, R. A. (2005) · Endocrinology · doi:10.1210/en.2004-1468 · Cited by 273
Nowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Self-citationStructure of an Extracellular gp130 Cytokine Receptor Signaling Complex
Chow, D.-C., He, X.-L., Snow, A. L., Rose-John, S., & Garcia, K. C. (2001) · Science · doi:10.1126/science.1058308 · Cited by 261
Self-citationScheidt-Nave, C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2032 · Cited by 255
Andus, T., Geiger, T., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180513 · Cited by 250
Stimulation of Hepatic Acute Phase Response by Cytokines and Glucocorticoidsa
BAUMANN, H., PROWSE, K. R., MARINKOVIĆ, S., WON, K., & JAHREIS, G. P. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24021.x · Cited by 240
STAT3 Acts as a Co-activator of Glucocorticoid Receptor Signaling
Zhang, Z., Jones, S., Hagood, J. S., Fuentes, N. L., & Fuller, G. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30607 · Cited by 240
SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130
Lehmann, U., Schmitz, J., Weissenbach, M., Sobota, R. M., Hörtner, M., Friederichs, K., Behrmann, I., Tsiaris, W., Sasaki, A., Schneider-Mergener, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210552200 · Cited by 236
Self-citationWunderlich, F. T., Ströhle, P., Könner, A. C., Gruber, S., Tovar, S., Brönneke, H. S., Juntti-Berggren, L., Li, L.-S., van Rooijen, N., Libert, C., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.011 · Cited by 229
In vivo production and function of IL-12 p40 homodimers
Heinzel, F. P., Hujer, A. M., Ahmed, F. N., & Rerko, R. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4381 · Cited by 229
Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling
Shi, H., Tzameli, I., Bjørbæk, C., & Flier, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403886200 · Cited by 222
Mechanisms of Glucocorticoid Receptor Action in Noninflammatory and Inflammatory Cells
Necela, B. M., & Cidlowski, J. A. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200402-005ms · Cited by 216
Nowell, M. A., Williams, A. S., Carty, S. A., Scheller, J., Hayes, A. J., Jones, G. W., Richards, P. J., Slinn, S., Ernst, M., Jenkins, B. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.613 · Cited by 215
Self-citationSignaling by IL-31 and functional consequences
Cornelissen, C., Lüscher-Firzlaff, J., Baron, J. M., & Lüscher, B. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.07.006 · Cited by 207
The Liver Biology and Pathobiology,
Narayan, R. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200204000-00032 · Cited by 204
LPS and TNFα induce SOCS3 mRNA and inhibit IL‐6‐induced activation of STAT3 in macrophages
Bode, J. G., Nimmesgern, A., Schmitz, J., Schaper, F., Schmitt, M., Frisch, W., Häussinger, D., Heinrich, P. C., & Graeve, L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01662-2 · Cited by 196
Self-citationGarbers, C., Thaiss, W., Jones, G. W., Waetzig, G. H., Lorenzen, I., Guilhot, F., Lissilaa, R., Ferlin, W. G., Grötzinger, J., Jones, S. A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295758 · Cited by 191
Self-citationA role for IL-27p28 as an antagonist of gp130-mediated signaling
Stumhofer, J. S., Tait, E. D., III, W. J. Q., Hosken, N., Spudy, B., Goenka, R., Fielding, C. A., O'Hara, A. C., Chen, Y., Jones, M. L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1957 · Cited by 184
Self-citationKlouche, M., Bhakdi, S., Hemmes, M., & Rose-John, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4583 · Cited by 178
Self-citationInterleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
Pedersen, B. K., & Febbraio, M. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01208.2006 · Cited by 177
Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases
Streetz, K. L., Tacke, F., Leifeld, L., Wüstefeld, T., Graw, A., Klein, C., Kamino, K., Spengler, U., Kreipe, H., Kubicka, S., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50268 · Cited by 167
Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells
Briso, E. M., Dienz, O., & Rincon, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7102 · Cited by 165
Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids
Bianchi, M., Meng, C., & Ivashkiv, L. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160099797 · Cited by 164
Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited
Schuster, B., Kovaleva, M., Sun, Y. E., Regenhard, P., Matthews, V. B., Grötzinger, J., Rose‐John, S., & Kallen, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210044200 · Cited by 162
Self-citationEssential role of STAT3 in cytokine‐driven NF‐κB‐mediated serum amyloid A gene expression
Hagihara, K., Nishikawa, T., Sugamata, Y., Song, J., Isobe, T., Taga, T., & Yoshizaki, K. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00900.x · Cited by 162
Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses
Müller-Newen, G., Küster, A., Hemmann, U., Keul, R., Horsten, U., Martens, A., Graeve, L., Wijdenes, J., & Heinrich, P. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6347 · Cited by 162
Dittrich, E., Haft, C. R., Muys, L., Heinrich, P. C., & Graeve, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5487 · Cited by 160
More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
Putoczki, T. L., & Ernst, M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410226 · Cited by 159
Inhibition of IL-6 and IL-10 Signaling and Stat Activation by Inflammatory and Stress Pathways1
Ahmed, S. T., & Ivashkiv, L. (2000) · Journal of Immunology · doi:10.4049/jimmunol.165.9.5227 · Cited by 159
Sands, W. A., Woolson, H. D., Milne, G. R., Rutherford, C. L., & Palmer, T. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00207-06 · Cited by 157
Hölscher, C. (2004) · Medical Microbiology and Immunology · doi:10.1007/s00430-003-0186-x · Cited by 156
Convergent Mechanisms for Recognition of Divergent Cytokines by the Shared Signaling Receptor gp130
Boulanger, M. J., Bankovich, A. J., Kortemme, T., Baker, D. A., & García, K. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00365-4 · Cited by 154
Oncostatin M and Leukemia Inhibitory Factor Do Not Use the Same Functional Receptor in Mice
Ichihara, M., Hara, T., Kim, H. J., Murate, T., & Miyajima, A. (1997) · Blood · doi:10.1182/blood.v90.1.165 · Cited by 152
Crabé, S., Guay-Giroux, A., Tormo, A. J., Duluc, D., Lissilaa, R., Guilhot, F., Bigouagou, U. M., Lefouili, F., Cognet, I., Ferlin, W. G., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901464 · Cited by 150
Yoshida, Y., Kumar, A., Koyama, Y., Peng, H., Arman, A., Boch, J. A., & Auron, P. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311498200 · Cited by 150
Glucocorticoid modulation of cytokine signaling
Rogatsky, I., & Ivashkiv, L. B. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00599.x · Cited by 150
Signaling of the Cardiotrophin-1 Receptor
Robledo, O., Fourcin, M., Chevalier, S., Guillet, C., Auguste, P., Pouplard-Barthelaix, A., Pennica, D., & Gascan, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4855 · Cited by 141
Suthaus, J., Stuhlmann-Laeisz, C. M., Tompkins, V. S., Rosean, T. R., Klapper, W., Tosato, G., Janz, S., Scheller, J., & Rose‐John, S. (2012) · Blood · doi:10.1182/blood-2011-09-377705 · Cited by 139
Self-citationGearing, D. P., Ziegler, S. F., Comeau, M. R., Friend, D. J., Thoma, B., Cosman, D. J., Park, L., & Mosley, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1119 · Cited by 138
The dual function of hepatic SOCS3 in insulin resistance in vivo
Torisu, T., Sato, N., Yoshiga, D., Kobayashi, T., Yoshioka, T., Mori, H., Iida, M., & Yoshimura, A. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01044.x · Cited by 132
Ehlting, C., Lai, W. S., Schaper, F., Brenndörfer, E. D., Matthes, R.-J., Heinrich, P. C., Ludwig, S., Blackshear, P. J., Gaestel, M., Häussinger, D., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2813 · Cited by 130
Self-citationLerner, L. R., Henriksen, M. A., Zhang, X., & Darnell, J. E., Jr. (2003) · Genes & Development · doi:10.1101/gad.1135003 · Cited by 130
Lechner, J., Welte, T., Tomasi, J. K., Bruno, P., Cairns, C. A., Gustafsson, J.-Α., & Doppler, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20954 · Cited by 127
Sachithanandan, N., Fam, B. C., Fynch, S., Dzamko, N. L., Watt, M. J., Wormald, S., Honeyman, J. E., Galić, S., Proietto, J., Andrikopoulos, S., et al. (2010) · Hepatology · doi:10.1002/hep.23861 · Cited by 108
Studies on the structure and regulation of the human hepatic interleukin‐6 receptor
Rose‐John, S., Schooltink, H., Lenz, D., Erich, H. I. P. P., Dufhues, G., SCHMITZ, H., Schiel, X., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15548.x · Cited by 107
Self-citationRadtke, S., Wüller, S., Yang, X., Lippok, B. E., Mütze, B., Mais, C., de Leur, H. S.-V., Bode, J. G., Gaestel, M., Heinrich, P. C., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.065326 · Cited by 107
Self-citationBaumann, H., Jahreis, G. P., & Morella, K. K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45700-6 · Cited by 100
Hitting a complex target: an update on interleukin-6 trans-signalling
Waetzig, G. H., & Rose‐John, S. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.660307 · Cited by 93
Self-citationShared Cytokine Signaling Receptors: Structural Insights from the Gp130 System
Boulanger, M. J., & García, K. C. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)68004-1 · Cited by 91
Takeda, T., Kurachi, H., Yamamoto, T., Nishio, Y., Nakatsuji, Y., Morishige, K., Miyake, A., & Murata, Y. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590323 · Cited by 88
Mooney, R. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01208a.2006 · Cited by 84
The Plasticity of Regulatory T Cell Function
Pillai, M. R., Collison, L. W., Wang, X., Finkelstein, D., Rehg, J. E., Boyd, K. L., Szymczak-Workman, A. L., Doggett, T. A., Griffith, T. S., Ferguson, T. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102173 · Cited by 83
Stat3 enhances transactivation of steroid hormone receptors
Miguel, F. D., Lee, S. O., Oñate, S. A., & Gao, A. C. (2003) · Nuclear Receptor · doi:10.1186/1478-1336-1-3 · Cited by 83
Non-redundant Signal Transduction of Interleukin-6-type Cytokines
Hermanns, H. M., Radtke, S., Schaper, F., Heinrich, P. C., & Behrmann, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005408200 · Cited by 80
Self-citationHypothalamic-Pituitary Cytokine Network
Kariagina, A., Romanenko, D., Ren, S.-G., & Chesnokova, V. (2003) · Endocrinology · doi:10.1210/en.2003-0669 · Cited by 79
Bode, J. G., Ludwig, S., Freitas, C. A. C., Schaper, F., Ruhl, M., Melmed, S. K., Heinrich, P. C., & Häussinger, D. (2001) · Biological Chemistry · doi:10.1515/bc.2001.178 · Cited by 75
Self-citationShimozato, O., Ugai, S., Chiyo, M., Takenobu, H., Nagakawa, H., Wada, A., Kawamura, K., Yamamoto, H., & Tagawa, M. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02257.x · Cited by 75
No inhibition of IL-27 signaling by soluble gp130
Scheller, J., Schuster, B., Hölscher, C., Yoshimoto, T., & Rose‐John, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.098 · Cited by 74
Self-citationMüller‐Newen, G., Köhne, C., Keul, R., Hemmann, U., Müller‐Esterl, W., Wijdenes, J., Brakenhoff, J. P. J., Hart, M. H. L., & Heinrich, P. C. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00837.x · Cited by 70
Self-citationPaul, C., Seiliez, I., Thissen, J., & Cam, A. L. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01395.x · Cited by 69
Henkel, J., Gärtner, D., Dorn, C., Hellerbrand, C., Schanze, N., Elz, S. R., & Püschel, G. P. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.47 · Cited by 66
Shimozato, O., Sato, A., Kawamura, K., Chiyo, M., Ma, G., Li, Q., & Tagawa, M. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03088.x · Cited by 65
Albrecht, U., Yang, X., Asselta, R., Keitel, V., Tenchini, M. L., Ludwig, S., Heinrich, P. C., Häussinger, D., Schaper, F., & Bode, J. G. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.007 · Cited by 63
Self-citationOrientational Constraints of the gp130 Intracellular Juxtamembrane Domain for Signaling
Greiser, J. S., Stroß, C., Heinrich, P. C., Behrmann, I., & Hermanns, H. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204113200 · Cited by 59
Self-citationPflanz, S., Tacken, I., Grötzinger, J., Jacques, Y., Dahmen, H., Heinrich, P. C., & Müller‐Newen, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00477-9 · Cited by 58
Self-citationAdam, N., Rabe, B., Suthaus, J., Grötzinger, J., Rose‐John, S., & Scheller, J. (2009) · Journal of Virology · doi:10.1128/jvi.01601-08 · Cited by 57
Self-citationInterleukin 1β inhibits interleukin 6–mediated rat γ fibrinogen gene expression
Zhang, Z., & Fuller, G. M. (2000) · Blood · doi:10.1182/blood.v96.10.3466 · Cited by 56
Bode, J. G., Fischer, R., Häussinger, D., Graeve, L., Heinrich, P. C., & Schaper, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1469 · Cited by 56
Self-citationWoolson, H. D., Thomson, V. S., Rutherford, C. L., Yarwood, S. J., & Palmer, T. M. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.07.009 · Cited by 53
Dibra, D., Cutrera, J. J., Xia, X., Kallakury, B., Mishra, L., & Li, S. (2011) · Hepatology · doi:10.1002/hep.24814 · Cited by 52
Dittrich, A., Khouri, C., Sackett, S. D., Ehlting, C., Böhmer, O., Albrecht, U., Bode, J. G., Trautwein, C., & Schaper, F. (2012) · Hepatology · doi:10.1002/hep.24655 · Cited by 51
Self-citationBode, J. G., Schweigart, J., Kehrmann, J., Ehlting, C., Schaper, F., Heinrich, P. C., & Häussinger, D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.257 · Cited by 50
Self-citationSchooltink, H., Stoyan, T., Lenz, D., SCHMITZ, H., Hirano, T., Kishimoto, T., Heinrich, P. C., & Rose‐John, S. (1991) · Biochemical Journal · doi:10.1042/bj2770659 · Cited by 49
Self-citationSommer, J., Effenberger, T., Volpi, E., Waetzig, G. H., Bernhardt, M., Suthaus, J., Garbers, C., Rose‐John, S., Floss, D. M., & Scheller, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.349167 · Cited by 46
Self-citationAhmed, S. T., Mayer, A. E., Ji, J., & Ivashkiv, L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.154 · Cited by 46
Ladenburger, A., Seehase, M., Kramer, B. W. W., Thomas, W., Wirbelauer, J., Speer, C. P., & Kunzmann, S. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00055.2010 · Cited by 41
Actemra poised to launch IL-6 inhibitors
Melton, L., & Coombs, A. (2008) · Nature Biotechnology · doi:10.1038/nbt0908-957 · Cited by 37
Kasutani, K., Itoh, N., Kanekiyo, M., Muto, N., & Tanaka, K. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8452 · Cited by 34
Raquet, X., Lamotte‐Brasseur, J., Bouillenne, F., & Frère, J. (1997) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(199701)27:1<96::aid-prot10>3.0.co;2-d · Cited by 34
Tato, C. M., & Cua, D. J. (2008) · Cell · doi:10.1016/j.cell.2008.01.002 · Cited by 33
Perret, D., Guillet, C., Elson, G., Froger, J., Plun‐Favreau, H., Rousseau, F., Chabbert, M., Gauchat, J., & Gascan, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407686200 · Cited by 31
Sobota, R., Müller, P. J., Heinrich, P., & Schaper, F. (2008) · Biochemical Journal · doi:10.1042/bj20071572 · Cited by 29
Self-citationSOCS-1 deficiency does not prevent diet-induced insulin resistance
Emanuelli, B., Macotela, Y., Boucher, J., & Kahn, C. R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.158 · Cited by 26
IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling
Traum, D., Timothee, P., Silver, J. S., Rose‐John, S., Ernst, M., & LaRosa, D. F. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411209 · Cited by 26
Self-citationKinter, A. L., Biswas, P., Alfano, M., Justement, J. S., Mantelli, B., Rizzi, C., Gatti, A., Vicenzi, E., Bressler, P. B., & Poli, G. (2001) · Molecular Medicine · doi:10.1007/bf03401957 · Cited by 24
Gaudy, A. M., Clementi, A. H., Campbell, J. S., Smrcka, A. V., & Mooney, R. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159111 · Cited by 24
FACTORS INFLUENCING THE EFFECT OF THE SOLUBLE IL-6 RECEPTOR ON IL-6 RESPONSES IN HepG2 HEPATOCYTES
Paysant, J., Blanqué, R., Vasse, M., Soria, C., Soria, J., & Gardner, C. R. (2000) · Cytokine · doi:10.1006/cyto.1999.0649 · Cited by 23
Overcoming insulin resistance with CNTF
Ahima, R. S. (2006) · Nature Medicine · doi:10.1038/nm0506-511 · Cited by 16
Glucagon counteracts interleukin-6 dependent gene expression by redundant action of Epac and PKA
Khouri, C., Dittrich, A., Sackett, S. D., Denecke, B., Trautwein, C., & Schaper, F. (2011) · Biological Chemistry · doi:10.1515/bc.2011.171 · Cited by 15
Self-citationЈovanović, J. A., Poznanović, G., Ivanović‐Matić, S., Bogojević, D., Mihailović, M., Uskoković, A. S., & Grigorov, I. (2010) · IUBMB Life · doi:10.1002/iub.313 · Cited by 13
Interleukin-6 signaling during the acute phase response of the liver
Bode, J. G., & Heinrich, P. C. (2001) · RWTH Publications (RWTH Aachen) · Cited by 6
Cited by
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Pro-inflammatory cytokines: The link between obesity and osteoarthritis
Wang, T., & He, C. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.002 · Cited by 1,034
Oxford IBD Cohort Investigators, West, N. R., Hegazy, A. N., Owens, B. M. J., Bullers, S. J., Linggi, B., Buonocore, S., Coccia, M., Görtz, D., This, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4307 · Cited by 811
Self-citationInterleukin-6 Family Cytokines
Rose-John, S. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028415 · Cited by 799
Self-citationRethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters
Del Giudice, M., & Gangestad, S. W. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.013 · Cited by 779
“Notably, regenerative processes in epithelial tissue (e.g., in the intestine) also seem to depend on classic IL-6 signaling (Chalaris et al., 2011; Garbers et al., 2012).”
Influential
Metadata
- Authors
- Garbers, C., Hermanns, H. M., Schaper, F., Müller-Newen, G., Grötzinger, J., Rose-John, S., & Scheller, J.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 23
- Issue
- 3
- Pages
- 85-97
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W2085433278
- Cited by
- 400
- References
- 143
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.